Stay updated on Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added to the page, and Revision: v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-20T19:51:45.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The interface now shows Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T18:06:55.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page now shows revision v3.4.2, replacing v3.4.1. This is a maintenance update and does not alter the study details, eligibility, or results.
    Difference
    0.1%
    Check dated 2026-02-13T01:42:30.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page now shows revision v3.4.1 instead of v3.4.0, indicating a minor metadata update with no impact on the study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T12:57:21.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-15T03:09:49.000Z thumbnail image
  9. Check
    112 days ago
    Change Detected
    Summary
    Added a new Locations section listing Florida, Maryland, Michigan, and Minnesota. Updated the page revision from v3.3.2 to v3.3.3 and removed the old location blocks.
    Difference
    0.5%
    Check dated 2025-12-24T13:59:17.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page.